[Ip-health] Oxfam statement on Novartis case

Mohga Kamal-Yanni mkamalyanni at oxfam.org.uk
Sun Sep 4 08:53:14 PDT 2011


Oxfam is closely watching the outcome of Novartis' endless and highly 
damaging challenge to Section 3(d) of India's Patent Act.  We are 
profoundly disappointed that Novartis has continued to pursue legal action 
against the Indian Government.  Five years ago, hundreds of thousands of 
people called upon Novartis to drop its legal challenge against the 
Indian.  Today, over 2 billion people still lack regular access to 
affordable medicines, and yet Novartis has persisted.  Oxfam is seriously 
concerned that if Novartis succeeds, it will lead to long term and 
profound changes in India's patent system that will undermine generic 
competition and access to affordable, low-cost medicines.


Best wishes
___________________________________
Mohga - A Proud Egyptian-Dictating to the computer so please forgive silly 
mistakes

Dr. Mohga M Kamal-Yanni
Senior health & HIV policy advisor
Oxfam GB
John Smith Drive, Oxford, OX4 2JY, UK
Tel:       + 44 (0) 1865 472290
Fax        + 44 (0) 1865 472245
Mobile   + 44 (0)777 62 55 884
Skype    Mohga Kamal-Yanni

Oxfam works with others to overcome poverty and suffering.

Oxfam GB is a member of Oxfam International and a company limited by guarantee registered in England No. 612172.
Registered office: Oxfam House, John Smith Drive, Cowley, Oxford, OX4 2JY.
A registered charity in England and Wales (no 202918) and Scotland (SC 039042)



More information about the Ip-health mailing list